• Tuberculosis and Respiratory Diseases
• /
• 제44권1호
• /
• pp.44-51
• /
• 1997

연구배경 : 최근 알려진 ${\gamma}{\delta}$ 수용체는 결핵균 감염의 초기에 제2형 주요 조직적합성 복합계(MHC class II)의 인식없이 결핵균 항원에 반응하여 세포성 면역반응을 나타냄이 보고되었다. 이에 연구자등은 페결핵환자와 결핵성 흉막염 환자, 그리고 다른 원인의 흉막염 환자사이에 T 림프구의 조성과 ${\gamma}{\delta}$ T-림프구 수의 차이를 관찰하였다. 방법 : 대상은 폐결핵환자 30예(이중 결핵성 흉막염환자 15예), 폐암 환자 12예(이중 악성 흉막염 환자 9예), 폐렴 7예(이중 폐렴성 흉막염 6예)등 모두 49예였다. 혈청 ADA(adenosine deaminase)활성도는 Hitachi 747 자동화학분석기에서 측정하였다. T 세포 림프구 아형의 분류는 lysed whole blood method로 anti-Leu4, anti-Leu3a, anti-Leu2a, anti HLA-DR 그리고 anti-TCR-${\gamma}{\delta}$-1를 이용하여 flow cytometer로 분석하였다. 결과 : 1. 말초혈액내 ${\gamma}{\delta}$-T 림프구의 평균치는 $4.8{\pm}4.6%$ 였고, 결핵군(29예) $5.5{\pm}4.5%$, 비결핵군(14예) $3.3{\pm}2.9%$(폐암군 $4.0{\pm}3.2%$, 폐렴군 $2.2{\pm}1.6%$로 유의한 차이는 없었다(p=0.24). 질병의 이환기간 1개월 이내의 환자중에서도 결핵군(20예) $6.4{\pm}6.6%$, 비결핵군(14예) $3.3{\pm}2.9%$ 으로 유의한 차이는 없었다(p=0.16)(Table 1). 2. 흉막액내 T 세포 림프구 아형중 CD4 림프구는 결핵성 흉막액에서는 $54.6{\pm}13.8%$, 비결핵성 흉막액에서는 $36.2{\pm}25.3%$(악성 흉막액 $38.4{\pm}23.8%$, 폐렴정 흉막액 $30.1{\pm}34.0%$ 결핵성 흉막액에서 의의있게 높았다(p=0.04)(Table 2). 3. 흉막염이 있던 환자에서 말초혈액내 ${\gamma}{\delta}$-T 림프구는 결핵성 흉막염군(14예)이 $7.0{\pm}9.0%$, 비결핵성 흉막염군(11예) $3.0{\pm}2.0%$ (악성 흉막염군 $3.1{\pm}2.2%$, 폐렴성 흉막염군 $2.7{\pm}1.7%$로 차이는 없었다(p=0.16). 흉막액내 ${\gamma}{\delta}$-T 림프구는 결핵성 흉막염군(15예)이 $3.9{\pm}2.9%$, 비결핵성 흉막염군(10예) $2.1{\pm}2.2%$(악성 흉막염군 $2.0{\pm}2.5%$, 폐렴성 흉막염군 $2.4{\pm}1.7%$ 로 유의한 차이가 없었다(p=0.12). 4. 환자의 연령이나 성별과 말초혈액내 ${\gamma}{\delta}$-T 림프구수와는 상관관계가 없었고, 폐결핵 환자에서 병변의 정도, 혈청 및 흉막액내 ADA와 ${\gamma}{\delta}$-T 림프구수와도 상관관계가 없었다. 결론 : 결핵성 흉막염환자에서 말초혈액 및 흉막액내 ${\gamma}{\delta}$-T 림프구수의 유의한 증가는 없어 다른 질환과의 감별진단에 도움이 되지 못할 것으로 생각되며, ${\gamma}{\delta}$-T 림프구의 증가는 결핵 초기 환자들을 대상으로 추가 연구가 필요할 것으로 생각된다.

• 한국패류학회지
• /
• 제30권2호
• /
• pp.155-163
• /
• 2014

동양달팽이의 EST 에서 serpin 유전자는 2가지 type이 추정되었다. Ns-serpin type 1 (partial) 서열의 코딩 영역은 총 819 bp 이었으며, 272개의 아미노산으로 이루어져 있었으며, Ns-serpin type 2 (partial) 의 코딩영역은 총 555 bp, 185개의 아미노산으로 이루어져 있었다. Laminarin 처리 전에는 Ns-serpin type 1이 2개 발현되었으며 처리 후에는 Ns-serpin type 2가 1개 발현되고 있었다. BLAST 결과를 바탕으로 유사도가 높은 17개의 참고 서열과 동양달팽이의 Ns-serpin type 1, 2의 아미노산 서열을 MEGA6 프로그램의 clustalW 엔진을 이용하여 multiple sequence alignment 를 수행한 결과, 척색동물의 포유강 9종, 조류강 1종, 양서강 1종과 척색동물인 해초강, 절지동물의 거미강 1종과 곤충강 1종이 같은 군으로 묶였으며, 연체동물문의 경우 동양달팽이의 두 가지 type 을 포함한 복족강 4종이 같은 군으로 묶이는 것을 확인하였다. Psipred 프로그램을 활용하여 예측한 2D 구조도 multiple align 및 phylodendrogram 결과와 연관이 있음을 확인할 수 있었다. EST를 통해 밝힌 동양달팽이의 두 가지 type의 Ns-serpin 서열은 Aplysia californica 등의 근연종들의 서열과 유사하였다. 본 연구에서는 무척추동물에서의 선천성 면역과 연관이 있는 것으로 잘 알려진 두 종류의 serpin 유전자 서열을 동양달팽이 EST 결과에서 발굴 하였으며, 동양달팽이에서도 여러 가지 type의 serpin 이 존재 할 수 있음을 입증하였다.

• 동국한의학연구소논문집
• /
• 제9권
• /
• pp.51-71
• /
• 2000

본 실험은 월국환합보중익기탕(越鞠丸合補中益氣湯)의 항스트레스효과를 조사하기 위하여 시행되었다. 월국환합보중익기탕(越鞠丸合補中益氣湯)이 전기자극으로 스트레스 상황을 유발시킨 mouse에게 끼친 B 임파구 면역계 변화를 mouse 혈청의 면양적혈구(綿羊赤血球)에 대한 적혈구 응집소가와 비장세포에서 B 세포 및 T 세포가 차지하는 백분율의 변화를 통하여 측정하였으며 이를 대조군과 비교 분석하였다. 혈청 항체가의 측정에서 스트레스 자극하에서 월국환합보중익기탕(越鞠丸合補中益氣湯)을 투여받은 그룹에서 약제를 투여받지 않은 그룹에 비하여 유의성 있는 차이를 보여(p<0.01) 면역 기능을 정상군의 수준으로 유지하는 결과를 얻었다. T 세포와 B 세포의 백분율의 측정에서도 스트레스 자극하에서 월국환합보중익기탕(越鞠丸合補中益氣湯)을 투여 받은 그룹에서 약제를 투여 받지 않은 그룹에 비하여 유의성 있는 차이를 보여(p<0.01) 면역 기능을 정상군의 수준으로 유지하는 결과를 얻었다. 실험결과들로 보아 월국환합보중익기탕(越鞠丸合補中益氣湯)이 체액성 면역 반응과 비장 내 면역 세포의 백분율을 정상의 수준으로 유지하는 효과를 보여 면역 기능의 이상에 응용할 수 있는 가능성을 제시한다고 사료된다.

• 한국동물위생학회지
• /
• 제20권1호
• /
• pp.103-125
• /
• 1997

An epidemiologic study on pleuropneumonia in the slaughter pigs(Chonan and Asan area, Chungnam province, Korea) during the period of January 1994 through December 1995 was conducted. Isolation of A pleuropneumoniae was attempted in 425 pigs with pneumonic lesions. Biochemical properties, antimicrobial susceptibility, serotypes and pathogenicity of isolated A pleuropneumoniae were investigated. In addition, outer membrane protein(OMP) of the Isolates were extracted to determine its properties and immunogenicity in both mice and piglets The results obtained through this study were summarized as followed ; 1. Of 3, 395 slaughter pigs, pleuropneumonia was observed in 425 pigs(10.6%). A pleuropneumoniae was isolated from 22 pigs(5.2%) out of 425 pigs with pneumonic lesions. The biochemical properties of all isolates were same as those of reference A pleuropneumoniae strain. Among 22 isolates, 9, 1 and 12 isolates were serovar 2, 3 and 5, respectively. 2. The results of antimicrobial susceptibility test revealed that the isolates showed high susceptibility to ciprofloxacin and cephalothin, moderate susceptibility to amikacin, gentamicin, kanamycin and streptomycin, and low susceptibility to erythromycin, tylosin and sulfadimethoxin. 3. The isolates were varied in pathogenicity to mice. Median lethal dose of LE9402(serovar 2) and LE9511(serovar 5) were $9.2{\times}10^7$ CFU and $2.8{\times}10^7$%CFU, respectively. Specific pneumonic lesions were observed from the infected mice with clinical signs. Bacteria recovery rate was high in the lung, but low In heart blood and tracheas. 4. Serovar 2 was found to be more pathogenic than serovar 5 in guinea pig. Mortality on guinea pigs inoculated with serovar 2($5.4{\times}10^8-5.4{\times}10^6$CFU) and serovar 5($2.8{\times}10^8-2.8{\times}10^6$ CFU) was 20~40% and 40~80%, respectively. A severe hemorrhagic lesions and focal pneumonic lesions were observed from dead guinea pigs. Bacteria recovery rate was relatively higher in the lung than that of other organs. 5. In the SDS-PAGE analysis, OMP-enriched fractions of both isolates and reference strains contain common peptide bands equivalent to molecular weight of 17, 27, 42, 52 and 95Kd. In addition to common peptide bands, the bands which are specific to each isolate were also observed. The profiles of Sephadex G25 fractions showed 3 major peaks. The common peptide bands which were observed by SDS-PAGE of the crude OMPs were found in the peaks 1 and 2. 6. The OMPs extracted from serovar 2(LE9402) and serovar 5(LE9511) provided high level of protection in mice(70~80%) and pigs(100%). All animals inoculated with OMPs were seroconverted, showing micro-agglutination titer of 640 to 1280.

• 한국식품영양과학회지
• /
• 제33권3호
• /
• pp.469-474
• /
• 2004

본 연구에 사용한 아라비녹실란화합물은 미강에서 추출한 헤미셀룰로즈에 표고버섯균사체 배양물에서 분리한 효소를 작용시켜 생성된 식물성다당류이며, PSP(polysaccharide peptide)는 담자균류의 일종인 Coliolus versicocor Sov-1의 균사체에서 추출 정제하여 얻은 단백다당체 성분이다. 이들에 대한 면역세포 활성화 효과, 항암 효과 및 알레르기 억제효과 등에 관한 실험 결과는 다음과 같다. 비장세포의 B cell과 T cell에 arabinoxylane과 PSP의 항체생성과 세포활성능을 조사한 결과 PFC형 성은 10 ∼ 15%, RFC검출은 10 ∼ 30% 증가하였다 복강침출세포로부터 대식세포의 탐식능 효과는 대조군에 비하여 PSP는 약 18%, arabinoxylane은 22% 정도 증가하였다. S-180 고형암에 의한 항암실험에서 arabinoxylane은 66.2%(p<0.01), PSP는 49.0%(p<0.05)의 억제 효과를 확인할 수 있었다. 복수암에 의한 수명 연장효과는 PSP, arabinoxylane이 대조군에 비해 다소의 수명연장효과가 나타났으며, PSP가 아라비녹실란에 비해 약간의 높은 수명연장효과가 나타났다. 항알레르기 효과를 보기 위한 PCA 역가를 측정한 결과는 대조군이 80인데 비해 PSP군은 40, arabinoxylane군은 20으로 대조군에 비하여 다소 경감되었으며, arabinoxylane군이 다소 우수한 결과를 보였다. 혈중 histamine 함량도 PCA와 유사한 결과로 arabinoxylane군과 PSP군이 히스타민 함량을 다소 감소시키는 경향을 보였다.

• 대한한방내과학회지
• /
• 제30권3호
• /
• pp.558-570
• /
• 2009

Background : Since March 2009, when the first patient of novel influenza A (H1N1) was reported, many deaths have occurred in North and Central America. The start of the 2009 influenza pandemic was declared by WHO Director-General Dr. Margaret Chan on 11 June 2009, and the level of influenza pandemic alert raised from phase 5 to phase 6. There was no vaccine yet developed, and many experts worried that the novel H1N1 virus could kill as many or more as did the influenza pandemic in 1918-1919. Objective : To evaluate the possibility of treatment for 2009 novel influenza A (H1N1) using herbal remedies and other non-conventional therapies. Methods : We researched the clinical studies for novel H1N1 influenza virus-related herbal medicine or non-conventional medicine treatment using internet search engines including PubMed and CNKI. In addition, we reviewed many reports and clinical practice guidelines (CPG) for influenza A (H1N1). Results : Two case series were selected after reviewing 701 papers, and two CPG published by the Chinese government and Jilin province identified. They reported that the clinical symptoms were no more significant than seasonal influenza, and the condition of patients more than 45 years old was milder than those less than 45 years old. There are no patients with gastric problems, and oseltamivir has been used at the same time in all patients. Conclusion : The efficacy and effectiveness of herbal medicine and other non-conventional treatments for the novel influenza A (H1N1) is questionable, and more studies are needed to draw a firm conclusion. However, in the severe acute respiratory syndrome (SARS) experience in 2002/2003, it was demonstrated that herbal medicine can relieve all symptoms of SARS patients, promote absorption of lung inflammation, improve the degree of blood oxygen saturation, regulate immunological functions, reduce the required dosage of glucocorticoid and other medicines, and reduce case fatality rate. In light of the current situation that there is no vaccine or conventional treatment yet available, the study of herbal medicine and other non-conventional therapies are also necessary for appropriate evaluation.

• 대한한방내과학회지
• /
• 제30권3호
• /
• pp.571-581
• /
• 2009

Background : Early in November 2002, severe acute respiratory syndrome (SARS) began to spread throughout thirty-two countries around the world. A total of 5,327 cases were reported in China, including 1,755 cases in Hong Kong and 655 in Taiwan. The total number of cases reported from Canada and Singapore was more than 200. The total number of SARS cases world-wide reached 8,437 with incidences. Mortality from SARS is estimated at around 11%. Under the guidance of the World Health Organization (WHO), clinical studies on the use of integrated herbal medicine and western medicine for treating SARS were carried out in China and Hong Kong. The official report suggested that integrated treatment was more effective than western medicine alone in clinical symptoms, lung inflammation, blood oxygen saturation, immunological functions and others. Objective : To overview the treatment principle and the prescriptions according to the regimens and the stages for SARS of the reports, and further to broaden our knowledge of treatment of acute infectious diseases using natural herbal medicine. Methods : We reviewed nine of WHO SARS reports that comprehensively described the principles and methods of treatment and summarized them into eight treatment methods. We analyzed the herbal formulae on the basis of their treatment principles, evaluated them in accordance with warm disease study, listed frequently used herbs, and assessed patent prescriptions and herbal injections that were mentioned in the reports. Results and Conclusion : The reports divided the course of SARS into 3 to 6 stages such as high fever stage, fastigium stage, and convalescent stage. Frequently used herbs were Radix Scutellariae, Radix Paeoniae, Radix Astragali, Semen Armeniacae, Radix Pseudostellariae, Radix Ophiopogonis, and Fructus Schizandrae. Herbal decoctions were the primary method of treatment, while extracts or injections were secondary. Prescriptions were mainly based on the warm disease study. SARS is a viral disease caused by corona virus, and herbal medicine is proven to be effective against it. We believe that evidences and experiences from SARS cases can be a good reference to further researches on acute infectious diseases.

• 대한한방내과학회지
• /
• 제26권2호
• /
• pp.440-452
• /
• 2005

Objective: In the winter of 2002, severe acute respiratory syndrome(SARS) began to spread throughout the world. More than 5,000 cases were reported in China, including over 1,700 cases in Hong Kong Special Administrative Region(Hong Kong SAR). The total number of cases reported from Canada and Singapore was more than 200. The total number of SARS cases world-wide reached 8,437 with incidences in 29 counties. Mortality from SARS is estimated at $10{\sim}12%$. When the SARS outbreak occurred in China, the State Administration of Traditional Chinese Medicine of China immediately initiated clinical research projects on the use of integrated herbal medicine and Western medicine for treating SARS. and, in Hong Kong SAR, research on the use of herbal medicine for the prevention and treatment of SARS. Reports were released during convalescence. The objective of this study is to overview twelve clinical SARS reports of WHO on the treatment of SARS with herbal medicine and evaluate the efficacy and safety of treatment of SARS with herbal medicine, and further to share experiences and knowledge of the treatment of SARS. Methods: Twelve clinical reports about SARS from the WHO were selected, overviewed and evaluated for efficacy and safety of treatments of SARS. Results and Conclusion: Twelve clinical reports about SARS showed that the integrated treatment may have advantages, and the advantages are reflected in the following findings: Firstly, herbal medicine is not targeted only at a specific etiology or a certain pathological link, but also at the pathological status of the patients at that particular time. Therefore, comprehensive readjustment was made through various angles, targets and channels to restore the balance of the body. Secondly, there are advantages in the differentiation of the disease and the treatment. Based on the various symptoms, herbal medicine enables the physician to adopt the most suitable principle, provide individual treatment, and to administer medicine in accordance with the actual process and nature of the illness. Thirdly, there are advantages in the results of the treatment; herbal medicine can relieve symptoms, promote absorption of lung inflammation, improve the degree of blood oxygen saturation, regulate immunological functions, reduce the required dosage of glucocorticoid and other Western medicines, and reduce case fatality rate, in addition to lowering the cost of treatment.

• 약학회지
• /
• 제48권6호
• /
• pp.335-344
• /
• 2004

Interleukin-2 (IL-2), a glycoprotein mainly secreted by CD4+ T helper Iymphocytes, has been developed to use recombinant cytokine to augment the immune response against cancer since IL-2 not only stimulates T Iymphocytes but also enhances natural killer (NK) cell activity. In order to evaluate the immunological safety of recombinant mouse IL-2 (rmIL-2) in cancer therapy, renal cell carcinoma was established in the flank by s.c. injection of renca cell line. Tumor-bearing BALB/c mice were treated with I.p. injections with $2{\times}10^5$ Lu rmIL-2. Even though the tumor size was diminished, there were not significant recovery of body and relative lymphoid organ weights including thymic atrophy in rmIL-2 immunotherapy. Distribution ratios of T cell subsets in thymus were analysed using flow cytometry. Without regard to dosage of rmIL-2, the ratio of CD3+CD4-CD8- T cells was increased in accordance with survival of solid tumor but that of CD4+CD8+ T cells was decreased dramatically. Emergence of autoantibodies (ANA, anti-dsDNA, and anti-histone) in blood was measured after rmIL-2 treatment. The results showed that the levels of ANA and anti-dsDNA did not significantly changed, but the level of anti-histone was increased significantly owing to rmIL-2 therapy. These results indicate rmIL-2 immunotherapy is to induce the autoimmune potential, and the anti-histone measurement as a biomarker of autoimmunity is useful in cancer immunotherapy.

• 대한의생명과학회지
• /
• 제20권4호
• /
• pp.250-255
• /
• 2014

Mycobacterium tuberculosis (MTB) resides and replicates inside macrophages. In our previous report, we reported that CD8+ T cell-mediated immune responses specific for the peptide derived from MTB RNA polymerase beta-subunit ($RpoB_{127-135}$) could be induced in TB patients expressing HLA-$A^*0201$ subtype. In order to examine whether $RpoB_{127-135}$ specific CD8+ T cells can recognize MTB infected macrophages in vitro, CD8+ T cell lines specific for $RpoB_{127-135}$ peptide were generated from peripheral blood mononuclear cells (PBMCs) of healthy HLA-$A^*0201$ subjects by in vitro immunization technique. In this study, we observed $RpoB_{127-135}$ specific CD8+ T cells could recognize and destroy macrophages infected with MTB for 2 to 4 days. $RpoB_{127-135}$ specific CD8+ T cell immune response was inducible from PBMC of healthy subjects expressing HLA-$A^*0206$ subtype, one of HLA-A2 supertype members. Next, we investigated the HLA-I processing mechanism of $RpoB_{127-135}$ peptide in MTB infected macrophages. As a result, the presentation of the MTB derived epitope peptide, $RpoB_{127-135}$, to CD8+ T cells was not inhibited by the treatment with brefeldin-A (ER-Golgi transport inhibitor) or lactacystin (proteasome inhibitor), which blocks the classical HLA-I processing pathway. However, $RpoB_{127-135}$ specific CD8+ T cell activity was blocked either by the blocking agent for the endocytosis (cytochalasin D) or by the blocking antibody (W6/32) for HLA-I molecules. Therefore, the $RpoB_{127-135}$ peptide may be processed by accessing the alternate HLA-I processing pathway. Understanding the processing and presentation mechanisms of the MTB derived proteins will help to improve the efficacy of vaccines and the efficiency of therapeutic agents for TB.